Treatment of a ruptured shallow trilobed cerebral aneurysm with the novel saccular endovascular aneurysm lattice (SEAL) device: A case report with one year follow-up.
Boris PabonVictor TorresKeith WoodwardMargarita CardozoBenedict TanVarun ChaubalAamir BadruddinThomas WolfeEdgard PereiraBrian JankowitzVincent CostalatDavid J AltschulClaire A LangerfordOsama O ZaidatPublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)
Intrasaccular flow disruption is a viable alternative to other endovascular treatments for saccular or wide-necked bifurcation intracranial aneurysms; however, wide neck aneurysms with irregular shapes or shallow depth may not be amenable to treatment currently available intrasaccular devices. Here, we present the first ever case report of the novel Saccular Endovascular Aneurysm Lattice Embolization System (SEAL™). The versatile utility of the SEAL™ device is demonstrated in a patient with acute subarachnoid hemorrhage (SAH) from a ruptured, complex, left middle cerebral artery (MCA) trilobed shallow wide-necked bifurcation aneurysm. Deployment and implantation of the SEAL device were technically feasible, safe, and conformed well to the irregular shape of the complex, ruptured aneurysm. Immediate total aneurysm occlusion was observed after implantation. Importantly, 1-year angiographic follow-up demonstrated durable, complete occlusion with no safety concerns. The SEAL device is a promising new novel technology which has the potential to treat very shallow aneurysms with limited height and irregular, multilobulated aneurysms.
Keyphrases
- subarachnoid hemorrhage
- abdominal aortic aneurysm
- coronary artery
- brain injury
- case report
- middle cerebral artery
- cerebral ischemia
- aortic dissection
- endovascular treatment
- body mass index
- internal carotid artery
- optical coherence tomography
- physical activity
- acute respiratory distress syndrome
- combination therapy
- drug induced
- risk assessment